| Pharmaceutical active ingredients: |
| Naproxen |
| Available forms, composition and doses of Dysmenalgit: |
| N / A |
| Dysmenalgit medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G02CC02 - NaproxenM01AE02 - NaproxenM02AA12 - Naproxen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Krewel Meuselbach |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dysman | Mefenamic Acid | Ashbourne Pharmaceuticals |
| Dysmen Forte | Acetaminophen; Mefenamic Acid | Svizera Healthcare; Sigma Laboratories |
| Dysmen Injections | Dicyclomine Hydrochloride | Svizera Healthcare |
| Dysmen Tablets | Dicyclomine Hydrochloride; Mefenamic Acid | Svizera Healthcare |
| Dysmen-500 | Mefenamic Acid | Svizera Healthcare; Sigma Laboratories |
| Dysmenorm | Agnus Castus; Apis Mellifica; Pulsatilla Pratensis; Rosmarinus Officinalis | Deutsche Homoopathie Union |
| Dysmenorrhoe-Gastreu S R75 | Caulophyllum; Cimicifuga; Magnesium Phosphoricum; Viburnum Opulus | Dr. Reckeweg Pharmazeutische Fabrik |
| Dysmenosyx | Chamomilla Recutita; Cimicifuga Racemosa; Sepia Officinalis | Syxyl |
| Dysmeryl | Acetaminophen; Dicyclomine Hydrochloride; Mefenamic Acid | Medley Pharmaceuticals |
| Dysne Inhal | Epinephrine Hydrochloride | Ratiopharm; Rougier Pharma |